← All companies

QGEN

Qiagen N.V.

QGEN NYSE Biological Products, (No Diagnostic Substances) EDGAR ↗

$42.33

+0.88 +2.12%

Key statistics

from XBRL data in SEC filings

Market cap

$9.18B

Revenue (TTM)

$2.09B

Net income (TTM)

$425M

EPS (TTM)

$1.94

P/E ratio

21.8

Dividend yield

0.59%

Free cash flow

$453M

Cash

$839M

Total assets

$6.28B

Gross margin

62.2%

52-week range

$32.53 – $57.82

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K May 8, 2026 6-K May 8, 2026 6-K May 1, 2026 20-F Mar 20, 2026 6-K Feb 6, 2026 6-K Dec 22, 2025 6-K Nov 6, 2025 6-K Nov 6, 2025 6-K Sep 2, 2025 6-K Aug 21, 2025 6-K Aug 7, 2025 6-K Jun 30, 2025 6-K May 13, 2025 6-K May 9, 2025 6-K Apr 9, 2025 20-F Mar 31, 2025 6-K Feb 7, 2025 6-K Jan 16, 2025 6-K Jan 13, 2025 6-K Nov 8, 2024 6-K Nov 8, 2024 6-K Nov 8, 2024 6-K Sep 4, 2024 6-K Sep 3, 2024 6-K Aug 2, 2024 6-K Aug 2, 2024 6-K Aug 2, 2024 6-K Jun 24, 2024 6-K Jun 6, 2024 6-K May 1, 2024 6-K May 1, 2024 20-F Mar 11, 2024 6-K Feb 8, 2024 6-K Jan 23, 2024 6-K Jan 8, 2024 6-K Nov 1, 2023 6-K Nov 1, 2023 6-K Nov 1, 2023 6-K Aug 10, 2023 6-K Aug 10, 2023